Zura Bio (ZURA) announced the appointment of Sandeep Kulkarni as CEO, effective January 21. Kulkarni will also continue serving as a director of Zura. Kulkarni succeeds Kim Davis, who has served as interim CEO since October 2025 following the commencement of a medical leave of absence by CEO Robert Lisicki. Lisicki is resigning as CEO and as a director, effective as of January 21. Davis will continue in her roles as chief operating officer, chief legal officer, and corporate secretary. Most recently, Kulkarni served as co-founder and CEO of Tourmaline Bio.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZURA: